Reassuring data from 539,478 individuals in the Copenhagen General Population Study, the Copenhagen City Heart Study, and the UK Biobank show that low Lp(a) level does not increase the risk of Alzheimer’s disease or vascular-related dementia (VRD).
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
